Senior Manager, Drug Substance Manufacturing

$144k - $176k

Workplace
On-site
Employment
Full-time

About this role

Aktis Oncology, Inc. is a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed by existing platform technologies. Aktis' most advanced program, AKY-1189, is a miniprotein radioconjugate targeting Nectin-4, with multi-indication potential across multiple tumor types. Aktis' second pipeline program, AKY-2519, is a miniprotein radioconjugate targeting B7-H3-expressing tumors, including prostate, lung, and other solid tumors. Aktis has a strategic collaboration with Eli Lilly and Company to leverage its miniprotein platform to develop novel radioconjugates outside Aktis' proprietary pipeline.

The Senior Manager, Drug Substance (DS) Manufacturing, is responsible for the day-to-day planning, coordination, and oversight of outsourced manufacturing activities for peptide drug substance across Aktis’ development portfolio. This individual will report to the Associate Director, DS Manufacturing and be an integral part of the Chemistry, Manufacturing, and Controls (CMC) team contributing to the development of multiple portfolio programs. The ideal candidate combines strong technical judgment with external-partner management and thrives in a fast-paced, mission-driven environment.

ESSENTIAL DUTIES / RESPONSIBILITIES

  • Manage day-to-day operations of external peptide/miniprotein manufacturing activities from development through clinical supply.
  • Manage and coordinate process development, scale-up, technology transfer, GMP manufacturing, and analytical testing activities at external partners. 
  • Support review of manufacturing documents, including protocols, batch records, campaign plans, and technical reports.
  • Monitor stability studies, including sample pulls, testing schedules, data availability, and report timelines, and escalate delays or unexpected results.
  • Drive investigations, deviations, change controls, and corrective and preventive actions in partnership with Quality.
  • Partner with Supply Chain and Operations to support material availability, manufacturing schedules, and demand planning.
  • Manage CDMO contracts, statements of work, purchase orders, change orders, invoice tracking, and budget reconciliation in partnership with senior team members, Finance, and Procurement.

BACKGROUND AND QUALIFICATIONS

  • Bachelor's degree or higher in chemistry, chemical engineering, biochemistry, pharmaceutical sciences, or related discipline
  • 5+ years of experience in peptide, biologics, or small-molecule process development and/or external manufacturing within the biotechnology or pharmaceutical industry
  • Direct experience with solid-phase peptide synthesis, analytical testing, and characterization is preferred
  • Experience managing CDMOs and coordinating multidisciplinary technical programs
  • Strong working knowledge of cGMP regulations and validation principles
  • Strong analytical, problem-solving, and communication skills
  • Excellent interpersonal skills and a collaborative approach with internal teams and external vendors
  • Able to work independently with minimal supervision
  • Self-starter who can prioritize and adapt in a fast-paced startup environment

Aktis Oncology is an Equal Opportunity Employer and does not discriminate on the basis of race, religion, color, sex, gender identity or expression, sexual orientation, age, disability, national origin, veteran status, or any other basis covered by appropriate law. Aktis Oncology is committed to promoting and maintaining a work environment in which all applicants, employees, and other individuals are treated with dignity and respect free from unlawful harassment, discrimination, or retaliation.

Apply to Aktis Oncology

Clera fills in Aktis Oncology's application for you.

How it works

Open the role in Clera

Sign in, and this role opens on your Clera job board, ready to apply.

Clera fills in the application

Clera fills the form from your profile and resume, and asks what's missing.

Track it in Clera

Each application you send shows up in your Clera tracker, sorted by stage.

Want Clera to find roles for you?

Ask your AI about this role

It knows you. Clera gives it the role.

Does this role fit my profile?

First time? Connect Clera once, about a minute.
One click above pre-fills the connector. Or by hand: Settings > Connectors > Add custom connector, paste https://mcp.getclera.com. Either way, sign in with the account you use on Clera and approve the consent screen.
https://mcp.getclera.com

Sign in with your Clera account. MCP docs

About Aktis Oncology

Aktis Oncology (Nasdaq: AKTS) is a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed by existing platform technologies.

The company has developed a proprietary miniprotein radioconjugate platform designed to selectively deliver the tumor-killing properties of radioisotopes to targeted tumors, while being rapidly cleared from normal organs and tissues to minimize systemic radiation exposure. Aktis’ most advanced pipeline program targets Nectin-4, a miniprotein radioconjugate with multi-indication potential across multiple tumor types. The company also maintains a strategic collaboration with Eli Lilly and Company to develop novel anticancer radiopharmaceuticals for targets outside of Aktis’ proprietary pipeline.

Team size
51-200 employees people
Industry
Biotechnology Research
Workplace
On-site